tradingkey.logo

Treace Medical Concepts Inc

TMCI
2.260USD
+0.220+10.78%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
143.97MCap. mercado
PérdidaP/E TTM

Treace Medical Concepts Inc

2.260
+0.220+10.78%

Más Datos de Treace Medical Concepts Inc Compañía

Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.

Información de Treace Medical Concepts Inc

Símbolo de cotizaciónTMCI
Nombre de la empresaTreace Medical Concepts Inc
Fecha de salida a bolsaApr 23, 2021
Director ejecutivoTreace (John T)
Número de empleados477
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 23
Dirección100 Palmetto Park Place
CiudadPONTE VEDRA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal32081
Teléfono19043735940
Sitio Webhttps://www.treace.com/
Símbolo de cotizaciónTMCI
Fecha de salida a bolsaApr 23, 2021
Director ejecutivoTreace (John T)

Ejecutivos de Treace Medical Concepts Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+23917.00%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
378.40K
+316000.00%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
273.50K
+248505.00%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+23917.00%
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Mark L. Hair
Mr. Mark L. Hair
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Lynn Lewis
Ms. Lynn Lewis
Investor Relations
Investor Relations
--
--
Ms. Elizabeth S. (Betsy) Hanna
Ms. Elizabeth S. (Betsy) Hanna
Independent Director
Independent Director
--
--
Mr. Aaron J. Berutti
Mr. Aaron J. Berutti
Senior Vice President - Sales
Senior Vice President - Sales
--
--
Ms. Jane E. Kiernan
Ms. Jane E. Kiernan
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
516.36K
+23917.00%
Dr. Sean F. Scanlan, Ph.D.
Dr. Sean F. Scanlan, Ph.D.
Chief Innovation Officer
Chief Innovation Officer
378.40K
+316000.00%
Mr. Scot Michael Elder
Mr. Scot Michael Elder
Chief Legal & Compliance Officer, Corporate Secretary
Chief Legal & Compliance Officer, Corporate Secretary
273.50K
+248505.00%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Independent Director
Independent Director
40.90K
+23917.00%
Mr. John T. Treace
Mr. John T. Treace
Chairman of the Board, Chief Executive Officer, Founder
Chairman of the Board, Chief Executive Officer, Founder
--
--
Mr. Mark L. Hair
Mr. Mark L. Hair
Chief Financial Officer
Chief Financial Officer
--
--

Desglose de ingresos

La empresa aún no ha revelado los datos relevantes.
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: dom., 1 de feb
Actualizado: dom., 1 de feb
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Treace (John T.)
18.72%
Armistice Capital LLC
9.91%
William Blair Investment Management, LLC
5.70%
BlackRock Institutional Trust Company, N.A.
5.11%
The Vanguard Group, Inc.
3.57%
Otro
56.99%
Accionistas
Accionistas
Proporción
Treace (John T.)
18.72%
Armistice Capital LLC
9.91%
William Blair Investment Management, LLC
5.70%
BlackRock Institutional Trust Company, N.A.
5.11%
The Vanguard Group, Inc.
3.57%
Otro
56.99%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
27.21%
Investment Advisor/Hedge Fund
22.63%
Hedge Fund
19.26%
Investment Advisor
15.78%
Research Firm
2.22%
Venture Capital
0.93%
Bank and Trust
0.32%
Pension Fund
0.04%
Family Office
0.03%
Otro
11.58%

Participación institucional

Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
332
38.84M
60.95%
-15.62M
2025Q3
338
38.30M
60.11%
-18.99M
2025Q2
369
55.28M
87.88%
-20.58M
2025Q1
378
54.40M
86.48%
-21.10M
2024Q4
366
54.35M
86.91%
-21.27M
2024Q3
360
58.92M
95.05%
-18.98M
2024Q2
346
57.87M
93.51%
-12.18M
2024Q1
319
59.01M
95.72%
-10.84M
2023Q4
318
57.97M
94.48%
-4.76M
2023Q3
299
57.85M
94.48%
-5.12M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Treace (John T.)
11.70M
18.37%
-159.07K
-1.34%
Mar 24, 2025
Armistice Capital LLC
6.32M
9.91%
+56.00K
+0.89%
Sep 30, 2025
William Blair Investment Management, LLC
3.63M
5.7%
+534.49K
+17.24%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
3.26M
5.11%
-26.43K
-0.80%
Sep 30, 2025
The Vanguard Group, Inc.
2.73M
4.29%
+6.24K
+0.23%
Sep 30, 2025
Gagnon Securities LLC
2.26M
3.54%
+8.09K
+0.36%
Sep 30, 2025
Treace (James T)
1.78M
2.79%
--
--
Mar 24, 2025
Millennium Management LLC
1.71M
2.68%
+192.93K
+12.72%
Sep 30, 2025
CIBC Private Wealth Management
1.69M
2.65%
-1.00K
-0.06%
Sep 30, 2025
First Eagle Investment Management, L.L.C.
1.24M
1.94%
+330.87K
+36.44%
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
iShares U.S. Medical Devices ETF
0.04%
Franklin US Small Cap Multifactor Index ETF
0.04%
iShares Russell 2000 Growth ETF
0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Fidelity Enhanced Small Cap ETF
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Morningstar Small-Cap ETF
0%
Ver más
iShares U.S. Medical Devices ETF
Proporción0.04%
Franklin US Small Cap Multifactor Index ETF
Proporción0.04%
iShares Russell 2000 Growth ETF
Proporción0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporción0.01%
Schwab U.S. Small-Cap ETF
Proporción0.01%
Global X Russell 2000 ETF
Proporción0.01%
ProShares Hedge Replication ETF
Proporción0.01%
Fidelity Enhanced Small Cap ETF
Proporción0.01%
Proshares Ultra Russell 2000
Proporción0.01%
iShares Morningstar Small-Cap ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI